Insider Ownership Activity for Nancy E. Denyes

SEC Forms 3/4/5 positions, issuer links, and transaction evidence for this reporting owner.

Linked issuers

1

Largest position

aTYR PHARMA INC

Disclosed value

$42.5K

Transaction activity

Available

Ownership signals CIK-linked ownership evidence from parsed SEC filings. 1 signal
Reporting-owner positions (Forms 3/4/5)

Forms 3/4/5 connect reporting owners to issuers, positions, and transactions disclosed to the SEC. They are filing-backed ownership signals, not a complete capitalization table.

Estimated position value

3/4/5
$42.5K

Estimated from parsed Forms 3/4/5 when filings include enough share and price data.

Linked issuers

3/4/5
1

Distinct issuers connected to this reporting owner in parsed SEC filings.

Latest parsed filing

SEC
04 Feb 2026

Most recent reporting-owner filing date in the parsed SEC record.

How to read Forms 3/4/5 positions
  • Reported values are filing-backed estimates from parsed SEC Forms 3/4/5 when the filing includes enough share and price data.
  • Use this as reporting-owner context, not as a full capitalization table or a public-float ownership breakdown.
Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
San Diego, CA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Nancy E. Denyes
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

Follow Filing Activity

Follow Nancy E. Denyes and return when a new Insider Trading filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.

Create free account and return here Already have an account? Sign in and return here

Reported issuer positions for Nancy E. Denyes

ATYR Forms 3/4/5

aTYR PHARMA INC

Relationship
General Counsel
Holdings value
$42,489
Past year net change
-$1,091
Change %
-2.5%
Report period
03 Feb 2026

Recent insider transactions for Nancy E. Denyes

Sym Company Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .